BRAF and ameloblastoma: In line with reports about other neoplasms that harbor a malignant counterpart, the frequency of the BRAF p.V600E mutation is higher in ameloblastoma (64% in conventional, 81% in unicystic, and 63% in peripheral) than in ameloblastic carcinoma (35%) [5].